26.81
Schlusskurs vom Vortag:
$24.41
Offen:
$24.71
24-Stunden-Volumen:
2.52M
Relative Volume:
1.10
Marktkapitalisierung:
$2.80B
Einnahmen:
$742.53M
Nettoeinkommen (Verlust:
$-32.56M
KGV:
-99.30
EPS:
-0.27
Netto-Cashflow:
$32.61M
1W Leistung:
+10.33%
1M Leistung:
+20.77%
6M Leistung:
+1.51%
1J Leistung:
+106.23%
Warby Parker Inc Stock (WRBY) Company Profile
Firmenname
Warby Parker Inc
Sektor
Telefon
(646) 847-7215
Adresse
233 SPRING STREET, NEW YORK
Vergleichen Sie WRBY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
WRBY
Warby Parker Inc
|
26.81 | 2.98B | 742.53M | -32.56M | 32.61M | -0.27 |
![]()
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.59B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Warby Parker Inc Stock (WRBY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-01 | Bestätigt | Telsey Advisory Group | Outperform |
2025-07-10 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
2025-04-30 | Hochstufung | Citigroup | Sell → Neutral |
2025-04-17 | Hochstufung | Loop Capital | Hold → Buy |
2025-02-28 | Bestätigt | Telsey Advisory Group | Outperform |
2025-02-25 | Eingeleitet | ROTH MKM | Neutral |
2025-02-05 | Herabstufung | Citigroup | Neutral → Sell |
2025-01-17 | Herabstufung | Evercore ISI | Outperform → In-line |
2024-11-19 | Bestätigt | Telsey Advisory Group | Outperform |
2024-11-08 | Bestätigt | Telsey Advisory Group | Outperform |
2024-11-07 | Hochstufung | William Blair | Mkt Perform → Outperform |
2024-10-21 | Hochstufung | Goldman | Neutral → Buy |
2024-08-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
2024-08-23 | Fortgesetzt | Piper Sandler | Overweight |
2023-10-12 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-03 | Hochstufung | Evercore ISI | In-line → Outperform |
2023-09-25 | Eingeleitet | UBS | Neutral |
2023-06-27 | Eingeleitet | William Blair | Mkt Perform |
2023-05-24 | Eingeleitet | JMP Securities | Mkt Perform |
2023-03-01 | Herabstufung | Citigroup | Buy → Neutral |
2023-02-07 | Eingeleitet | BTIG Research | Neutral |
2022-12-15 | Eingeleitet | Wolfe Research | Outperform |
2022-07-22 | Eingeleitet | Piper Sandler | Overweight |
2022-05-18 | Herabstufung | Goldman | Buy → Neutral |
2022-03-31 | Eingeleitet | Stifel | Hold |
2021-10-26 | Eingeleitet | Citigroup | Buy |
2021-10-25 | Eingeleitet | Cowen | Outperform |
2021-10-25 | Eingeleitet | Evercore ISI | In-line |
2021-10-25 | Eingeleitet | Goldman | Buy |
2021-10-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-10-25 | Eingeleitet | Robert W. Baird | Outperform |
2021-10-25 | Eingeleitet | Telsey Advisory Group | Outperform |
Alle ansehen
Warby Parker Inc Aktie (WRBY) Neueste Nachrichten
How Warby Parker’s Rising Sales and Leadership Changes Could Shape the WRBY Investment Story - simplywall.st
Warby Parker’s Earnings Call: Growth and Strategic Moves - TipRanks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytek Biosciences (CTKB), Natera (NTRA) and Warby Parker (WRBY) - The Globe and Mail
Warby Parker Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Warby Parker Gets Price Target Hikes On Strong Q2 Report, Google AI Glasses Optimism - MSN
Citizens JMP reiterates Market Perform rating on Warby Parker stock By Investing.com - Investing.com Canada
Citizens JMP reiterates Market Perform rating on Warby Parker stock - Investing.com
Mixed Analyst Opinions on Healthcare Stocks Cytek Biosciences, Natera, and Warby Parker - AInvest
How Warby Parker Has Kept the Price of Glasses at $95 for 15 YearsWSJ - The Wall Street Journal
Warby Parker raises 2025 revenue guidance to up to $888M as Google AI eyewear partnership and store expansion drive growth - MSN
Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates - MSN
Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics - MSN
Warby Parker Inc. (NYSE:WRBY) Q2 2025 Earnings Call Transcript - Insider Monkey
How to build a dashboard for Warby Parker Inc. stockFree Real Time Alerts Based on AI Prediction - Newser
What MACD signals say about Warby Parker Inc.Free Real Trader Watchlist of Hot Stocks - Newser
Real time alert setup for Warby Parker Inc. performanceSmart Entry Signals for Active Traders - Newser
Warby Parker 2025 Q2 Earnings Strong Performance as Net Income Surges 74.1% - AInvest
Historical volatility pattern of Warby Parker Inc. visualizedInvestment Position Summary with Timeframe Forecast - Newser
Using data filters to optimize entry into Warby Parker Inc.Expert-Backed High Yield Stock Watchlist - Newser
What data driven models say about Warby Parker Inc.’s futureAlpha Stock Picks with Chart Confirmation - Newser
Is now a turning point for Warby Parker Inc.Daily Trade Setup Forecast with Confidence - Newser
CFOs On the Move: Week ending Aug. 8 - CFO.com
UBS Hikes Price Target on Warby Parker to $23 From $20, Maintains Neutral Rating - MarketScreener
Warby Parker CFO Steve Miller Resigns - The Globe and Mail
Stifel raises Warby Parker stock price target to $22 on improved outlook - Investing.com Australia
Warby Parker Inc. SEC 10-Q Report - TradingView
Warby Parker Inc (WRBY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Zurcher Kantonalbank Zurich Cantonalbank Sells 64,236 Shares of Warby Parker Inc. (NYSE:WRBY) - Defense World
Warby Parker Reports Strong Q2 2025 Results - TipRanks
Warby Parker Reports Revenue Growth for Q2, Raises Full-Year Outlook and Announces Leadership Update - VisionMonday.com
Q2 Earnings Forecast for Warby Parker Issued By Roth Capital - Defense World
Warby Parker's Dual-Engine Growth Strategy: AI-Integrated Innovation and Physical Expansion Redefine Eyewear Market - AInvest
Warby Parker's Q2 2025: Unpacking Contradictions in Economic Outlook, Customer Stability, and Growth Strategies - AInvest
WRBY’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Warby Parker’s Strategic Growth Amidst External Challenges: A Hold Rating Analysis - TipRanks
Warby Parker Shares Slip After Giving Up Early Gains Despite Strong Q2 Results and Raised Outlook - Benzinga
Warby Parker’s (NYSE:WRBY) Q2 Sales Top Estimates - Yahoo Finance
Warby Parker stock price target raised to $28 by BTIG on Q2 beat - Investing.com Australia
Warby Parker Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Warby Parker Q2 2025 misses EPS forecasts, revenue grows - Investing.com Canada
Warby Parker to end home try-on program as it focuses on stores, digital experience - Retail Dive
Warby Parker’s Strong Financial Performance and Growth Prospects Amid CFO Transition - TipRanks
Warby Parker Soars 7.22%—Is This the Dawn of a New Retail Era? - AInvest
Warby Parker Q2 2025 slides: 14% revenue growth, raises full-year outlook - Investing.com Canada
Warby Parker stock hits 52-week high at 29.32 USD By Investing.com - Investing.com Australia
Warby Parker's Strategic Turnaround: A Glimpse of Profitability and AI-Driven Growth in a Competitive Market - AInvest
Warby Parker reports Q2 EPS (1c), consensus 7c - TipRanks
Warby Parker Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Warby Parker Q2 Loss Narrows, Revenue Rises; Lifts 2025 Outlook - MarketScreener
Warby Parker 2Q Earnings Beat Expectations, CFO to Step Down - AInvest
Warby Parker 2Q Loss Narrows as Revenue Rises; Finance Chief to Step Down - MarketScreener
Finanzdaten der Warby Parker Inc-Aktie (WRBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):